Preparation Of 2-benzimidazolyl-6-morpholino-4-heterocyclylpyrimidine Derivatives As PI3K And MTOR Inhibitors For Treatment Of Proliferative Disease

About Us
Software
MCPairs
Overview
Discover MCPairs, an explainable AI platform using Matched Molecular Pair Analysis (MMPA).

Pricing and Plans
Find the right platform for your business.

Modules
RuleDesign®
A design tool for fixing compound properties.

CoreDesign®
A design tool for scaffold hops.

SpotDesign®
A design tool for testing ideas before synthesis.

SARkush®
Automated SAR analysis for Markush-like structures.

MyPairs
Find your Matched Pairs and Rules.

pMMPA
Permutate SAR across your series.

Toxophores
Predict potential toxic liabilities.

Pharmacophores
Predict potential binding.

Compound to Pairs
Instant structure activity relationship analysis.

Cheminformatics Tools
Access to MedChemica’s Cheminformatics Toolbox.
- MCPairs Overview
- Pricing and Plans
Consulting
Case Studies
Insights
Contact Us

14. Preparation of 2-benzimidazolyl-6-morpholino-4-heterocyclylpyrimidine derivatives as PI3K and mTOR inhibitors for treatment of proliferative disease
Butterworth, Sam; Griffen, Edward Jolyon; Pass, Martin WO 2008032028 A1.

Bradley Shaw2017-11-07T15:53:11+00:00

There are two parts to our business – Software and Consulting. Get in touch today to find out how we can help you save time and money.

Get In Touch

Navigation

Company info

connect

01625 402740

enquiries@medchemica.com

subscribe to our newsletter

MCPairs In Practice: What To Make Next

Join our webinar on 5 Oct at 3-4pm BST

Let’s Make Things Happen

Contact Info

41 Avada Avenue, Florida, 98765

403-904-3623

Unlock Your Online GrowthUnlock Your Online Growth

MCPairs

Modules

Share This Article

Navigation

Company info

connect

subscribe to our newsletter

Let’s Make Things Happen

Contact Info